Head of Canada’s Drug Price Regulator Resigns Same Week as Colleague Steps Down

Federal Health Minister Jean-Yves Duclos speaks to the media at the Hamilton Convention Centre, in Hamilton, Ont., during the Liberal cabinet retreat, on Jan. 23, 2023. The Canadian Press/Nick Iwanyshyn

The executive director of Canada’s drug pricing regulator is stepping down—just days after another member resigned because of concerns that the federal government was undermining the regulator’s work.

Douglas Clark, executive director of the Patented Medicine Prices Review Board, announced today he will be leaving his post after almost a decade with the regulator.